Sequence homology within the morbilliviruses.

PubWeight™: 1.56‹?› | Rank: Top 4%

🔗 View Article (PMC 254686)

Published in J Virol on February 01, 1985

Authors

S Rozenblatt, O Eizenberg, R Ben-Levy, V Lavie, W J Bellini

Articles citing this

Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J (1987) 2.67

HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol (1989) 2.11

Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol (1992) 1.87

Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line. J Virol (1988) 1.84

Detection of human papillomavirus DNA in formalin-fixed tissues by in situ hybridization after amplification by polymerase chain reaction. Am J Pathol (1991) 1.75

Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus. J Virol (1985) 1.75

Matrix genes of measles virus and canine distemper virus: cloning, nucleotide sequences, and deduced amino acid sequences. J Virol (1986) 1.74

Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction. Gut (1996) 1.41

Detection of canine distemper virus nucleoprotein RNA by reverse transcription-PCR using serum, whole blood, and cerebrospinal fluid from dogs with distemper. J Clin Microbiol (1999) 1.38

Nucleotide sequence of the bovine parainfluenza 3 virus genome: its 3' end and the genes of NP, P, C and M proteins. Nucleic Acids Res (1987) 1.34

Measles virus synthesizes both leaderless and leader-containing polyadenylated RNAs in vivo. J Virol (1989) 1.22

Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection. J Virol (1997) 1.15

Leader sequence distinguishes between translatable and encapsidated measles virus RNAs. J Virol (1990) 1.13

Structure and function of bicistronic RNA encoding the phosphoprotein and matrix protein of measles virus. J Virol (1987) 1.09

Functional cDNA library for efficient expression of measles virus-specific gene products in primate cells. J Virol (1986) 0.98

Development of a challenge-protective vaccine concept by modification of the viral RNA-dependent RNA polymerase of canine distemper virus. J Virol (2007) 0.96

Polymerase chain reaction for detection of measles virus in clinical samples. J Clin Microbiol (1993) 0.96

Establishment of a rescue system for canine distemper virus. J Virol (2000) 0.95

Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J Virol (2001) 0.91

Conformational maturation of measles virus nucleocapsid protein. J Virol (1993) 0.89

Sequence of 2,617 nucleotides from the 3' end of Newcastle disease virus genome RNA and the predicted amino acid sequence of viral NP protein. Nucleic Acids Res (1986) 0.89

An amino acid of human parainfluenza virus type 3 nucleoprotein is critical for template function and cytoplasmic inclusion body formation. J Virol (2013) 0.83

Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines. J Virol (2000) 0.81

Rapid accumulation of measles virus leader RNA in the nucleus of infected HeLa cells and human lymphoid cells. J Virol (1991) 0.78

Alteration of the leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus. J Virol (1999) 0.77

Evaluation of the LTK63 adjuvant effect on cellular immune responses to measles virus nucleoprotein. Afr Health Sci (2011) 0.77

Highly individual patterns of virus-immune IgG effector responses in humans. Med Microbiol Immunol (2016) 0.75

Antibody Response to Paramyxoviruses in Paget's Disease of Bone. Calcif Tissue Int (2017) 0.75

Articles cited by this

Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68

Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A (1972) 83.88

Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16

Transcriptional control in the production of liver-specific mRNAs. Cell (1981) 9.35

Measles-virus antibody and antigen in subacute sclerosing panencephalitis. Lancet (1967) 5.44

Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62

Polycistronic vesicular stomatitis virus RNA transcripts. Proc Natl Acad Sci U S A (1980) 2.16

Persistent infection of cells in culture by measles virus. I. Development and characteristics of HeLa sublines persistently infected with complete virus. J Bacteriol (1966) 1.99

The polypeptides of canine distemper virus: synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses. Virology (1980) 1.69

Cloning of DNA complementary to the measles virus mRNA encoding nucleocapsid protein. Proc Natl Acad Sci U S A (1980) 1.50

Electron microscopic evidence for splicing of SV40 late mRNAs. Cell (1978) 1.50

Immunological relationships between homologous structural polypeptides of measles and canine distemper virus. J Gen Virol (1980) 1.40

Cloning of DNA corresponding to four different measles virus genomic regions. Virology (1984) 1.38

Cloning and characterization of DNA complementary to the measles virus mRNA encoding hemagglutinin and matrix protein. J Virol (1982) 1.32

Characterization of measles virus-specific proteins synthesized in vivo and in vitro from acutely and persistently infected cells. J Virol (1979) 1.31

Structural and functional characterization of Newcastle disease virus polycistronic RNA species. J Virol (1984) 1.28

Positive identification of a measles virus cDNA clone encoding a region of the phosphoprotein. J Virol (1984) 1.11

Antigenic relationships between measles and canine distemper viruses: comparison of immune response in animals and humans to individual virus-specific polypeptides. Proc Natl Acad Sci U S A (1979) 1.09

IMMUNOLOGICAL RELATIONSHIPS OF MEASLES, DISTEMPER, AND RINDERPEST VIRUSES. Proc Natl Acad Sci U S A (1960) 1.03

Molecular cloning of the nucleoprotein gene of canine distemper virus. J Gen Virol (1984) 0.92

Polypeptides of canine distemper virus strains derived from dogs with chronic neurological diseases. Virology (1982) 0.86

Neutralizing antibodies to canine distemper and measles virus in multiple sclerosis. J Neurol Sci (1979) 0.83

Synthesis of a unique polypeptide in measles virus-infected BGM cells. J Gen Virol (1982) 0.81

Articles by these authors

Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39

Simian virus 40 DNA directs synthesis of authentic viral polypeptides in a linked transcription-translation cell-free system. Proc Natl Acad Sci U S A (1975) 4.98

Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology (1995) 3.87

Measles virus P gene codes for two proteins. J Virol (1985) 3.31

Infectious viral DNA of murine leukemia virus. Proc Natl Acad Sci U S A (1975) 3.09

Cell-free translation of messenger RNA of simian virus 40: synthesis of the major capsid protein. Proc Natl Acad Sci U S A (1974) 3.04

A single gene and a pseudogene for the cellular tumour antigen p53. Nature (1984) 2.98

Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63

Molecular biology of Hendra and Nipah viruses. Microbes Infect (2001) 2.33

Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res (1996) 2.30

Multiple nuclear proteins in liver cells are bound to hepatitis B virus enhancer element and its upstream sequences. EMBO J (1987) 2.22

DNA probes specific for Entamoeba histolytica possessing pathogenic and nonpathogenic zymodemes. Infect Immun (1989) 2.22

Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology (2004) 2.18

Direct biochemical mapping of eukaryotic viral DNA by means of a linked transcription-translation cell-free system. Proc Natl Acad Sci U S A (1976) 2.17

Expression of the gene encoding the 17-kilodalton antigen from Rickettsia rickettsii: transcription and posttranslational modification. J Bacteriol (1988) 2.14

Entamoeba histolytica ribosomal RNA genes are carried on palindromic circular DNA molecules. Mol Biochem Parasitol (1989) 1.92

Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology (1992) 1.89

Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res (1994) 1.89

A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol (1998) 1.88

Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol (1992) 1.87

Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology (1997) 1.83

Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus. J Virol (1985) 1.75

Matrix genes of measles virus and canine distemper virus: cloning, nucleotide sequences, and deduced amino acid sequences. J Virol (1986) 1.74

Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. EMBO J (1993) 1.74

Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol (2000) 1.72

Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68

Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J Infect Dis (1996) 1.66

Human cytoplasmic superoxide dismutase cDNA clone: a probe for studying the molecular biology of Down syndrome. Proc Natl Acad Sci U S A (1982) 1.64

Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62

Sequence analysis of the 17-kilodalton-antigen gene from Rickettsia rickettsii. J Bacteriol (1987) 1.61

High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter. EMBO J (1986) 1.58

Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis (1997) 1.56

Cloning of DNA complementary to the measles virus mRNA encoding nucleocapsid protein. Proc Natl Acad Sci U S A (1980) 1.50

Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology (1986) 1.49

Molecular characterization of the polymerase gene and genomic termini of Nipah virus. Virology (2001) 1.47

Covalently linked cell and SV40-specific sequences in an RNA from productively infected cells. Virology (1972) 1.46

Separation and quantitation of intracellular forms of poliovirus RNA by agarose gel electrophoresis. Biochemistry (1977) 1.43

A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J Pharmacol Exp Ther (2001) 1.43

Functional organization of the hepatitis B virus enhancer. Mol Cell Biol (1990) 1.42

New genetic group of measles virus isolated in the People's Republic of China. Virus Res (1998) 1.42

Molecular epidemiology of measles virus. Curr Top Microbiol Immunol (2009) 1.41

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. J Virol (2000) 1.39

Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J Virol (1999) 1.38

Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis (1998) 1.36

Cloning and characterization of DNA complementary to the measles virus mRNA encoding hemagglutinin and matrix protein. J Virol (1982) 1.32

Acquisition of sequences homologous to host DNA by closed circular simian virus 40 DNA. 3. Host sequences. J Virol (1973) 1.32

Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J Med Virol (1993) 1.31

Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology (1994) 1.31

Characterization of measles virus-specific proteins synthesized in vivo and in vitro from acutely and persistently infected cells. J Virol (1979) 1.31

Functional and structural interactions between measles virus hemagglutinin and CD46. J Virol (1995) 1.29

Detection of measles virus RNA in lymphocytes from peripheral-blood and brain perivascular infiltrates of patients with subacute sclerosing panencephalitis. N Engl J Med (1985) 1.29

Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21. Proc Natl Acad Sci U S A (1993) 1.28

Acquisition of sequences homologous to host DNA by closed circular simian virus 40 DNA. II. Further studies on the serial passage of virus clones. J Virol (1973) 1.25

Entamoeba histolytica: cloning and characterization of actin cDNA. Mol Biochem Parasitol (1987) 1.25

Identification of anisomycin-activated kinases p45 and p55 in murine cells as MAPKAP kinase-2. Oncogene (1996) 1.19

Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus. J Virol (1995) 1.19

A single element within the hepatitis B virus enhancer binds multiple proteins and responds to multiple stimuli. J Virol (1990) 1.19

Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol (1995) 1.19

Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol (1986) 1.18

Genetic characterization of contemporary wild-type measles viruses from Vietnam and the People's Republic of China: identification of two genotypes within clade H. Virus Res (2001) 1.18

The hemagglutinin envelope protein of canine distemper virus (CDV) confers cell tropism as illustrated by CDV and measles virus complementation analysis. J Virol (1995) 1.18

Roles for a cytoplasmic tyrosine and tyrosine kinase activity in the interactions of Neu receptors with coated pits. J Biol Chem (1995) 1.17

Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation. J Biol Chem (1992) 1.15

Timing of development of measles-specific immunoglobulin M and G after primary measles vaccination. Clin Diagn Lab Immunol (1999) 1.14

Infective substructures of measles virus from acutely and persistently infected cells. J Virol (1979) 1.13

Measles eradication: is it in our future? Am J Public Health (2000) 1.12

Positive identification of a measles virus cDNA clone encoding a region of the phosphoprotein. J Virol (1984) 1.11

Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3. Oncogene (1999) 1.10

Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J (1996) 1.10

Measles virus strain variations. Curr Top Microbiol Immunol (1995) 1.08

The diversity of measles virus in the United Kingdom, 1992-1995. J Gen Virol (1997) 1.08

Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J Med Virol (1998) 1.08

Human cellular immune response to measles virus polypeptides. J Virol (1984) 1.07

Purification of measles virus with preservation of infectivity and antigenicity. J Gen Virol (1979) 1.06

Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis (1993) 1.05

Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. JAMA (1996) 1.05

Antigenic analysis of current wild type and vaccine strains of measles virus. J Infect Dis (1994) 1.05

Nucleotide sequence analysis of an Entamoeba histolytica ferredoxin gene. Mol Biochem Parasitol (1988) 1.04

Immune reactivity of the purified hemagglutinin of measles virus. Infect Immun (1981) 1.04

Recovery of visual response of injured adult rat optic nerves treated with transglutaminase. Science (1994) 1.04

Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol (2014) 1.03

Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis (1999) 1.03

Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J Pediatr (1994) 1.02

Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples. J Med Virol (2001) 1.02

Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics (1996) 1.02

Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol (2009) 1.01

Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients. Emerg Infect Dis (2001) 1.00

Monospecific antibody to the haemagglutinin of measles virus. J Gen Virol (1980) 1.00

Tumor necrosis factor facilitates regeneration of injured central nervous system axons. Brain Res (1991) 0.99

Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody. Virology (2000) 0.99

Biosynthesis of measles virus hemagglutinin in persistently infected cells. Arch Virol (1983) 0.99

Expression of GTP-dependent and GTP-independent tissue-type transglutaminase in cytokine-treated rat brain astrocytes. J Biol Chem (1997) 0.98

Antibodies to the structural polypeptides of measles virus following acute infection and in SSPE. Clin Exp Immunol (1980) 0.98

Subacute sclerosing panencephalitis: detection of measles virus RNA in appendix lymphoid tissue before clinical signs. Br Med J (Clin Res Ed) (1986) 0.98